Repository logo
 
Publication

Update on 1-benzylpiperazine (BZP) party pills

dc.contributor.authorMonteiro, Márcia Sá
dc.contributor.authorBastos, Maria de Lourdes
dc.contributor.authorGuedes de Pinho, Paula
dc.contributor.authorCarvalho, Márcia
dc.date.accessioned2021-06-30T13:49:09Z
dc.date.available2021-06-30T13:49:09Z
dc.date.issued2013
dc.description.abstractN-benzylpiperazine (BZP) has become popular among recreational drug users as the major active ingredient of "party pills" due to its stimulant and euphoric properties. Before BZP legal restrictions, these pills were sold as a safe and legal alternative to classical amphetamines like ecstasy. New Zealand, given the size of its legal market prior to BZP control, is the country that most contributed to the knowledge about the patterns of use, motivations and positive and adverse effects resulting from its consumption, though the interest in BZP-party pills was observed all over the world. The use of these pills has been associated with hospitalizations for adverse events and continued availability over the Internet makes this intoxication a continued concern. This paper provides a review on the characteristics of BZP recreational use, specifically the target population, patterns and motivations of use, and evolution of legal status. Moreover, the in vivo and in vitro studies performed in order to understand its pharmacology, toxicology and kinetics are also discussed. Lastly, analytical methodologies for the identification of BZP in clinical and forensic settings are addressed.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1007/s00204-013-1057-xpt_PT
dc.identifier.eissn1432-0738
dc.identifier.issn0340-5761
dc.identifier.urihttp://hdl.handle.net/10284/9986
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relationThis work received financial support from “Fundação para a Ciência e Tecnologia” (FCT) through grant no. PEst-C/EQB/LA0006/2011.pt_PT
dc.subjectBenzylpiperazinept_PT
dc.subjectPiperazine derivativept_PT
dc.subjectLegal highspt_PT
dc.subjectPharmacokineticspt_PT
dc.subjectPharmacodynamicspt_PT
dc.subjectToxicitypt_PT
dc.titleUpdate on 1-benzylpiperazine (BZP) party pillspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage947pt_PT
oaire.citation.issue6pt_PT
oaire.citation.startPage929pt_PT
oaire.citation.titleArchives of Toxicologypt_PT
oaire.citation.volume87pt_PT
person.familyNameCarvalho
person.givenNameMarcia
person.identifier2017111
person.identifier.ciencia-id8B10-171E-E63E
person.identifier.orcid0000-0001-9884-4751
person.identifier.ridD-5999-2013
person.identifier.scopus-author-id7201413997
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication3837b828-ba57-47f7-a811-cce65e4922c6
relation.isAuthorOfPublication.latestForDiscovery3837b828-ba57-47f7-a811-cce65e4922c6

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Update on 1-benzylpiperazine (BZP) party pills.pdf
Size:
858.19 KB
Format:
Adobe Portable Document Format